- Home
- RELY vs ALKS Comparison
RELY vs ALKS Comparison
Compare RELY & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELY
- ALKS
- Stock Information
- Founded
- RELY 2011
- ALKS 1987
- Country
- RELY United States
- ALKS Ireland
- Employees
- RELY N/A
- ALKS N/A
- Industry
- RELY Computer Software: Prepackaged Software
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- RELY Technology
- ALKS Health Care
- Exchange
- RELY Nasdaq
- ALKS Nasdaq
- Market Cap
- RELY 4.6B
- ALKS 5.1B
- IPO Year
- RELY 2021
- ALKS 1991
- Fundamental
- Price
- RELY $17.02
- ALKS $29.22
- Analyst Decision
- RELY Buy
- ALKS Strong Buy
- Analyst Count
- RELY 10
- ALKS 13
- Target Price
- RELY $27.40
- ALKS $40.23
- AVG Volume (30 Days)
- RELY 3.6M
- ALKS 1.8M
- Earning Date
- RELY 07-30-2025
- ALKS 07-29-2025
- Dividend Yield
- RELY N/A
- ALKS N/A
- EPS Growth
- RELY N/A
- ALKS N/A
- EPS
- RELY N/A
- ALKS 2.09
- Revenue
- RELY $1,356,469,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- RELY $27.85
- ALKS N/A
- Revenue Next Year
- RELY $20.30
- ALKS $4.18
- P/E Ratio
- RELY N/A
- ALKS $13.97
- Revenue Growth
- RELY 34.37
- ALKS N/A
- 52 Week Low
- RELY $12.43
- ALKS $24.48
- 52 Week High
- RELY $27.32
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- RELY 27.22
- ALKS 45.86
- Support Level
- RELY $17.07
- ALKS $28.69
- Resistance Level
- RELY $17.75
- ALKS $29.74
- Average True Range (ATR)
- RELY 0.58
- ALKS 0.76
- MACD
- RELY -0.07
- ALKS 0.03
- Stochastic Oscillator
- RELY 5.78
- ALKS 30.29
About RELY Remitly Global Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.